Product Information
GABAPENTIN ER 600 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $1.0250 per EA under NDC 50228052490. Its NADAC has been published 39 times since Jan 7, 2026.
FDA first approved this application on Sep 19, 2025. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the gabapentin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
600 mg/1
Manufacturer
ScieGen Pharmaceuticals, Inc.NDC
50228052490
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA218491FDA Approved
9/19/2025
TE Code
AB2
On Market Since
9/20/2025
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN ER 600 MG TABLET has been published 39 times since Jan 7, 2026, and over the history we have for it it has declined 32.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0250 per EA |
|---|---|
| All-time high | $1.5217 (Jan 14, 2026) |
| All-time low | $0.9225 (Jul 22, 2026) |
| 52-week high | $1.5217 |
| 52-week low | $0.9225 |
| Median price | $1.1212 |
| Average price | $1.1515 |
| Largest weekly change | -11.0% (Jun 17, 2026) |
| Weeks tracked | 39 |
| Tracking since | Jan 7, 2026 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 94% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ScieGen Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
gabapentin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GABAPENTIN ER 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN ER 600 MG TABLET, manufactured by ScieGen Pharmaceuticals, Inc., is $1.0250 per EA (NDC 50228052490), effective Sep 30, 2026.
How has the price of GABAPENTIN ER 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for GABAPENTIN ER 600 MG TABLET has declined 32.6%. It has been tracked across 39 weekly CMS publications since Jan 7, 2026.
What are the highest and lowest recorded NADAC prices for GABAPENTIN ER 600 MG TABLET?
Since Jan 7, 2026, the NADAC for GABAPENTIN ER 600 MG TABLET has ranged from a low of $0.9225 (Jul 22, 2026) to a high of $1.5217 (Jan 14, 2026), with a median of $1.1212 per EA.
Are there cheaper alternatives to GABAPENTIN ER 600 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GABAPENTIN 600 MG TABLET, is $0.0640 per EA — about 94% below GABAPENTIN ER 600 MG TABLET.
Who manufactures GABAPENTIN ER 600 MG TABLET?
GABAPENTIN ER 600 MG TABLET (NDC 50228052490) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.